L-arginine for fatigue: what the study showed
How fatigue and sleep scores changed at two L-arginine doses in adults with persistent fatigue.
Key points
- In adults aged 30–59 with persistent fatigue, 6 g of L-arginine per day reduced mean fatigue scores by 4.18 points more than placebo over eight weeks. At 3 g per day there was no fatigue advantage. [1] See the evidence 1
- In the same study, the sleep score at 3 g per day was slightly better than placebo. Sleep was a secondary measure in people with fatigue, not a separate insomnia study. [1] See the evidence 1
Practical guide
Check the conclusions and whether they apply to your situation.
A study of adults with persistent fatigue compared two L-arginine doses with placebo. Fatigue and sleep were assessed separately.
Key points
Why these conclusions
Fatigue and sleep in the study
Adults aged 30–59 from South Korea with persistent fatigue took liquid L-arginine at 3 or 6 g per day or placebo for eight weeks. In the 6 g group, fatigue scores fell by 6.41 points versus 2.23 with placebo; mean fatigue remained above the inclusion threshold. At 3 g there was no fatigue advantage. [1]
At 3 g per day, the sleep score after adjustment for baseline was 1.19 points better than placebo. This was a secondary result of the same study; no correction for the number of comparisons was applied to it. Certainty for both outcomes is low, 2 out of 4. [1]
The FSS fatigue score fell by an average of 6.41 points with arginine and 2.23 with placebo: a difference of 4.18 points on a scale from 9 to 63. The difference persisted after correction for multiple comparisons (p=0.024). Mean fatigue decreased but remained above the study inclusion threshold; 3 g per day showed no advantage.
| Parameter | Data |
|---|---|
| Result | The FSS fatigue score fell by an average of 6.41 points with arginine and 2.23 with placebo: a difference of 4.18 points on a scale from 9 to 63. The difference persisted after correction for multiple comparisons (p=0.024). Mean fatigue decreased but remained above the study inclusion threshold; 3 g per day showed no advantage. |
| Participants | 120 adults aged 30–59 from South Korea with persistent fatigue; 119 entered the analysis: 40 on placebo, 40 on 3 g and 39 on 6 g of arginine per day |
| Form | Liquid L-arginine supplement in 20 g sachets |
| Dose | 6 g L-arginine per day: one sachet containing 3 g twice daily |
| Dose basis | 6 g L-arginine per day: one sachet containing 3 g twice daily |
| Comparator | Similar-looking liquid supplement without arginine, one sachet twice daily |
| Duration | 8 weeks |
| Certainty | 2/4: The study was registered after completion, and the main analysis set was changed during preparation of the article. The assessment is based on one study with two doses; the 6 g result persisted after correction for multiple comparisons. Participants were already experiencing fatigue; a reduction does not mean it disappeared completely. |
| Volume of evidence | 1 publication on one study |
| Sources | [1] |
At 3 g per day, the PSQI sleep questionnaire score was 1.19 points better than placebo after adjustment for baseline (95% confidence interval: 0.33 to 2.06 points; a lower score means better sleep). Sleep was a secondary measure; no correction for the number of comparisons was applied.
| Parameter | Data |
|---|---|
| Result | At 3 g per day, the PSQI sleep questionnaire score was 1.19 points better than placebo after adjustment for baseline (95% confidence interval: 0.33 to 2.06 points; a lower score means better sleep). Sleep was a secondary measure; no correction for the number of comparisons was applied. |
| Participants | 120 adults aged 30–59 from South Korea with persistent fatigue; 119 entered the analysis: 40 on placebo, 40 on 3 g and 39 on 6 g of arginine per day |
| Form | Liquid L-arginine supplement in 20 g sachets |
| Dose | 3 g L-arginine per day: one sachet containing 1.5 g twice daily |
| Dose basis | 3 g L-arginine per day: one sachet containing 1.5 g twice daily |
| Comparator | Similar-looking liquid supplement without arginine, one sachet twice daily |
| Duration | 8 weeks |
| Certainty | 2/4: Sleep was a secondary measure among many comparisons, without correction for their number. The study was registered after completion; some baseline sleep measures differed. A small improvement was found in people with fatigue, not in a separate insomnia study. |
| Volume of evidence | 1 publication on one study |
| Sources | [1] |
Information from the source
Arginine supplements are not recommended after a recent myocardial infarction. In a study of 153 patients after infarction, with a target dose of 9 g per day over six months, six people died in the arginine group and none in the placebo group; recruitment was stopped. These data concern people after infarction. Nausea, abdominal pain, diarrhea, bloating, headache, gout and allergic reactions are possible. Arginine may also lower blood pressure and increase airway inflammation and asthma symptoms; if you have asthma or allergies, discuss the supplement with a doctor before taking it. During pregnancy and breastfeeding, Health Canada recommends consulting a doctor about use. The monograph is intended for adults aged 18 and over; adult regimens in the table are not pediatric doses. If you have cardiovascular disease, discuss use with a doctor before increasing physical activity. For doses of 3 g per day or more, Health Canada separately specifies a consultation for use longer than eight weeks in this group. According to an NIH review, doses up to 9 g per day were generally well tolerated for several days or weeks. At 9–30 g per day, gastrointestinal complaints and a small reduction in blood pressure were reported more often; the safety of high doses for longer than three months remains unclear. [2] [3] [4] [5]
Sources
- Effects of Oral L-Arginine on Everyday Persistent Fatigue, Sleep, and Post-Exercise Lactate Recovery in Community-Dwelling Working-Age Adults: A Double-Blind, Placebo-Controlled Randomized Trial. https://www.mdpi.com/2072-6643/18/20/3375
- Dietary Supplements for Exercise and Athletic Performance — Health Professional Fact Sheet (NIH ODS). https://ods.od.nih.gov/factsheets/ExerciseAndAthleticPerformance-HealthProfessional/
- L-Arginine Therapy in Acute Myocardial Infarction: The Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) Randomized Clinical Trial. https://doi.org/10.1001/jama.295.1.58
- Health Canada — Natural Health Product: L-Arginine (25 July 2025). https://webprod.hc-sc.gc.ca/nhpid-bdipsn/dbImages/mono_arginine-l_english.pdf
- L-arginine (Mayo Clinic). https://www.mayoclinic.org/drugs-supplements-l-arginine/art-20364681
Methodology: Subpages evidence-led supplement pipeline v1